Menu
GeneBe

2-74462544-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006302.3(MOGS):c.1245C>G(p.Ile415Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00284 in 1,610,242 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. I415I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0098 ( 22 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 16 hom. )

Consequence

MOGS
NM_006302.3 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0140
Variant links:
Genes affected
MOGS (HGNC:24862): (mannosyl-oligosaccharide glucosidase) This gene encodes the first enzyme in the N-linked oligosaccharide processing pathway. The enzyme cleaves the distal alpha-1,2-linked glucose residue from the Glc(3)-Man(9)-GlcNAc(2) oligosaccharide precursor. This protein is located in the lumen of the endoplasmic reticulum. Defects in this gene are a cause of type IIb congenital disorder of glycosylation (CDGIIb). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016709566).
BP6
Variant 2-74462544-G-C is Benign according to our data. Variant chr2-74462544-G-C is described in ClinVar as [Benign]. Clinvar id is 382459.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00978 (1490/152316) while in subpopulation AFR AF= 0.0318 (1322/41568). AF 95% confidence interval is 0.0304. There are 22 homozygotes in gnomad4. There are 696 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MOGSNM_006302.3 linkuse as main transcriptc.1245C>G p.Ile415Met missense_variant 4/4 ENST00000448666.7
MOGSNM_001146158.2 linkuse as main transcriptc.927C>G p.Ile309Met missense_variant 5/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MOGSENST00000448666.7 linkuse as main transcriptc.1245C>G p.Ile415Met missense_variant 4/41 NM_006302.3 P1Q13724-1

Frequencies

GnomAD3 genomes
AF:
0.00973
AC:
1481
AN:
152198
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0317
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00123
Gnomad OTH
AF:
0.00574
GnomAD3 exomes
AF:
0.00342
AC:
849
AN:
247952
Hom.:
7
AF XY:
0.00304
AC XY:
409
AN XY:
134608
show subpopulations
Gnomad AFR exome
AF:
0.0315
Gnomad AMR exome
AF:
0.00128
Gnomad ASJ exome
AF:
0.00336
Gnomad EAS exome
AF:
0.000111
Gnomad SAS exome
AF:
0.00545
Gnomad FIN exome
AF:
0.0000467
Gnomad NFE exome
AF:
0.000872
Gnomad OTH exome
AF:
0.00282
GnomAD4 exome
AF:
0.00211
AC:
3078
AN:
1457926
Hom.:
16
Cov.:
31
AF XY:
0.00210
AC XY:
1524
AN XY:
724700
show subpopulations
Gnomad4 AFR exome
AF:
0.0312
Gnomad4 AMR exome
AF:
0.00133
Gnomad4 ASJ exome
AF:
0.00263
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.00558
Gnomad4 FIN exome
AF:
0.000263
Gnomad4 NFE exome
AF:
0.00106
Gnomad4 OTH exome
AF:
0.00316
GnomAD4 genome
AF:
0.00978
AC:
1490
AN:
152316
Hom.:
22
Cov.:
33
AF XY:
0.00935
AC XY:
696
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.0318
Gnomad4 AMR
AF:
0.00327
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00290
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00123
Gnomad4 OTH
AF:
0.00568
Alfa
AF:
0.00151
Hom.:
3
Bravo
AF:
0.0109
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.0288
AC:
113
ESP6500EA
AF:
0.00145
AC:
12
ExAC
AF:
0.00397
AC:
480
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.00115
EpiControl
AF:
0.000771

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxApr 21, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
MOGS-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.61
Cadd
Benign
7.2
Dann
Benign
0.72
DEOGEN2
Benign
0.0036
T;T;.;.;.;.
Eigen
Benign
-0.97
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.023
N
MetaRNN
Benign
0.0017
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L;L;.;.;.;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.29
T
REVEL
Benign
0.020
Polyphen
0.0
B;B;.;.;.;.
Vest4
0.070, 0.080
MVP
0.34
MPC
0.24
ClinPred
0.000024
T
GERP RS
1.7
Varity_R
0.050
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34838944; hg19: chr2-74689671; API